The global fluorescent immunoassay market is experiencing steady growth, fueled by the increasing demand for advanced diagnostic technologies and the rising prevalence of infectious and chronic diseases. According to The Insight Partners, the market is projected to grow from US$ 2.81 billion in 2023 to US$ 4.51 billion by 2031, registering a CAGR of 5.8% during 2023–2031. Fluorescent...